GALLUZZO, Aldo
 Distribuzione geografica
Continente #
NA - Nord America 4.634
EU - Europa 2.381
AS - Asia 631
SA - Sud America 11
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 1
Totale 7.673
Nazione #
US - Stati Uniti d'America 4.623
IT - Italia 632
FI - Finlandia 550
CN - Cina 513
UA - Ucraina 492
DE - Germania 168
IE - Irlanda 157
GB - Regno Unito 102
SE - Svezia 96
FR - Francia 52
RU - Federazione Russa 41
IN - India 37
BE - Belgio 32
KR - Corea 31
TR - Turchia 15
RO - Romania 14
IR - Iran 13
CH - Svizzera 11
NL - Olanda 10
PL - Polonia 8
HK - Hong Kong 7
BR - Brasile 6
CA - Canada 6
EU - Europa 6
AT - Austria 4
IL - Israele 4
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
MX - Messico 3
BG - Bulgaria 2
CL - Cile 2
JM - Giamaica 2
JP - Giappone 2
LB - Libano 2
NP - Nepal 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HU - Ungheria 1
LT - Lituania 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 7.673
Città #
Fairfield 535
Chandler 428
Ashburn 410
Houston 361
Ann Arbor 334
Woodbridge 329
Jacksonville 280
Wilmington 232
Seattle 196
Cambridge 179
Dublin 157
Palermo 151
Medford 112
Des Moines 106
Nanjing 96
Princeton 75
Dearborn 71
New York 60
Tulsa 58
Altamura 54
Changsha 46
Shenyang 45
Jinan 44
Boardman 42
San Diego 41
Hebei 36
Beijing 34
Lawrence 33
Brussels 31
Seongnam 27
Jiaxing 26
Nanchang 26
Kumar 25
Venice 25
Ningbo 24
Milan 19
Ludwigshafen am Rhein 18
Tianjin 18
Falls Church 16
Verona 16
Hangzhou 14
Izmir 14
Zhengzhou 14
Frankfurt 13
Saint Petersburg 13
Washington 13
Durham 12
Taizhou 12
Guangzhou 11
Tehran 11
London 10
Redwood City 10
Auburn Hills 9
Haikou 9
Taiyuan 9
Bologna 8
Chicago 8
Düsseldorf 8
Orange 8
Kunming 7
Munich 7
Phoenix 7
San Mateo 7
San Paolo di Civitate 7
Montegrotto Terme 6
Atlanta 5
Lanzhou 5
Los Angeles 5
Norwalk 5
Rome 5
Hefei 4
Kilburn 4
Pune 4
São Luís 4
Bremen 3
Central District 3
Edmonton 3
Fuzhou 3
Moscow 3
Polska 3
Sirmione 3
Arnhem 2
Bari 2
Cape Town 2
Catania 2
Catanzaro 2
Central 2
Changchun 2
Chieti 2
Den Haag 2
Edinburgh 2
Foggia 2
Genoa 2
Gillingham 2
Hong Kong 2
Hyderabad 2
Indiana 2
Kingston 2
L'aquila 2
La Spezia 2
Totale 5.163
Nome #
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 305
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory 214
In vitro generation of pancreatic endocrine cells from human adult fibroblast-like limbal stem cells 190
In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine β-TC3 Cell Line 174
The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome 173
In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines 171
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 168
BRAFV600E mutation, TIMP-1 up-regulation and NF-{kappa}B activation: closing the loop on the papillary thyroid cancer trilogy. 168
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency 159
Use of Glargine in Pregnant Women with Type 1 Diabetes Mellitus: A Case-Control Study 156
OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes. 154
Fine-Needle Aspiration (FNAB) Molecular Analysis for the Diagnosis of Papillary Thyroid Carcinoma through BRAFv600E mutation and RET/PTC rearrangement 147
Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. 147
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 146
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 143
Development of a fuzzy expert system for the control of glycemia in type 1 diabetic patients 143
Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance 140
Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience 138
Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2 135
Differente pattern di espressione di citochine a fenotipo Th1 e Th2 nei pazienti affetti da diabete di tipo 1 (T1DM) e con associata tireopatia autoimmune (AITD) 134
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 132
Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes 121
Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. 119
Il c-peptide come marker principale nella storia naturale del Diabete tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze 116
Cellule Staminali Pancreatiche 112
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial 110
Systolic flow peak of inferior thyroid arteries in Graves’disease: A predictive parameter for the ophalmopathy development. 106
Different Th1/Th2 cytokine expression in Type 1 diabetes mellitus patients (T1DM) alone or associated with autoimmune thyroid disease (AITD) 106
Effect of lercanidipine compared with ramipril on albumin excretion rate in hyprtensive Type 2 diabetic patients with microalbuminuria. DIAL Study (Ddiabete, Ipertensione, Albuminuria, Lercanidipina) 105
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. 105
null 104
Cornea in acromegalic patients as a possible target of growth hormone action. 103
Valutazione dell'insulinoresistenza tramite un test pasto standard 98
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. 98
High expression of peroxisome proliferator-activated receptor gamma (PPRgamma) in infiltrating lymphocytes from glands with Hashimoto's thyroiditis. 91
Difficoltà di identificazione della sindrome MEN2B ad esordio infantile: iter diagnostico. 91
The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. 91
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. 90
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. 90
GH-suppression test in acromegaly: comparison between OGTT and chocolate test 89
Glycemic durability of rosiglitazone, metformin or glyburide monotherapy 87
Distinct subsets of intrathyroidal regulatory CD4+CD25+ and CD8+CD25+ T cells in Hashimoto's thyroiditis: Potential role in the neoplastic cell growth. 87
null 87
Sviluppo di un sistema di supporto decisionale tipo Fuzzy per il controllo della glicemia post-prandiale nel diabete mellito tipo 1 86
Decremento delle cellule T regolatorie (Treg) CD4+CD25+FOXP3+ nei linfociti periferici dei pazienti affetti da diabete di tipo 1. 85
Rotterdam consensus, NIH and EAS: comparison among the three different diagnostic criteria for the diagnosis of PCOS. 84
Leptina e adiponectina nella valutazione del compenso glicometabolico in corso di diabete mellito di tipo 1 normopeso. 83
Insulin resistance and polycystic ovary syndrome. 82
Changes in lipid profile and adipokine levels in GH deficient children during GH replacement therapy. 82
Visceral Adiposity Index (VAI): A Reliable Indicator Of Visceral Fat Function Associated With Cardiometabolic Risk. 81
Peak systolic velocity (PSV) in inferior thyroid arteries (ITA) at Graves'disease onset is predictive of the risk for ophtalmopathy development 80
Identification and enrichment of thyroid stem cells in anaplastic cell lines 80
No association between BRAFV660E and metalloproteinase activity in anaplastic thyroid cell lines 80
Amplificazione real-time allele-specifica per l'individuazione della mutazione V600E del B-RAF nel carcinoma papillare su agoaspirato tiroideo. 80
Th1 and Th2 cell phenotypes in AITD: role of allergy in Graves’ disease 77
L’uso del hrTSH nel follow up del microcarcinoma tiroideo in pazienti sottoposti a tiroidectomia totale 77
Up-regulation of c-FLIPshort and Reduction of Activation-Induced Cell Death in T-cells from Patients with Type 1 Diabetes 77
Congenital anomaly rate in offspring of Italian mothers with type 1 diabetes treated with insulin lyspro during pregnancy 75
Adrenal incidentaloma: a new contributing factor in metabolic syndrome 75
Detection of BRAFv600E mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens. 75
Iter diagnostico "rapido" per un caso di MEN IIb in un giovane adolescente 75
L’espressione di citochine TH1 e TH2 nei pazienti affetti da tireopatia autoimmune (AITD) e diabete di tipo 1 74
L’espressione del “peroxisome proliferator-activated gamma” (PPARgamma) nelle tireopatie croniche autoimmuni 72
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. 69
Low hrTSH-Tg levels in patients affected by papillary thyroid microcarcinoma are influenced by pre-surgery L-thyroxine therapy. 68
Antitumor effect of aminobisphosphonates on anaplastic thyroid carcinoma cell lines. 67
Complete biochemical control and oituitary adenoma disappearance in a child with gigantism: efficay of octreotide therapy 67
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni contro regolatori. 62
Hypothyroidism induced by esophageal adenocarcinoma metastates: a case report 56
Insulin sensitivity and visceral adiposity index (VAI) in women with functional secondary amenorrhea. 54
Oligomenorrhea in PCOS is characterized by a high visceral adiposity index (VAI): a likely condition of cardiometabolic risk. 50
Increated central corneal thickness in acromegalic patients 47
Influences of obesity and weight loss on thyroid hormones. A 3-3.5-year follow-up study on obese subjects with surgical bilio-pancreatic by-pass 47
Phenotipic characteristics of GAD Antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe 38
Valutazione morfologica e funzionale surrenalica nell’acromegalia 38
Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome 29
Adrenal morphology and function in acromegalic patients in relation to disease activity. 26
Totale 7.941
Categoria #
all - tutte 22.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.523


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019392 0 0 0 0 0 0 0 0 0 65 165 162
2019/20202.002 239 95 147 147 225 229 192 118 176 83 263 88
2020/20211.043 44 107 46 96 99 19 114 97 155 58 107 101
2021/2022954 14 207 12 39 77 34 42 39 89 132 91 178
2022/20231.149 111 194 25 122 141 183 89 75 148 10 42 9
2023/2024443 21 88 17 43 47 144 32 40 9 2 0 0
Totale 7.941